Immunovant Files 8-K: Regulatory, Other Events & Exhibits
Ticker: IMVT · Form: 8-K · Filed: Mar 19, 2025 · CIK: 1764013
Sentiment: neutral
Topics: 8-k, regulatory-disclosure, financials
TL;DR
Immunovant dropped an 8-K on 3/19 covering Reg FD, other events, and financials.
AI Summary
Immunovant, Inc. filed an 8-K on March 19, 2025, reporting on various events. The filing includes information related to Regulation FD disclosures, other events, and financial statements and exhibits. The company, incorporated in Delaware, is involved in the biological products sector.
Why It Matters
This 8-K filing provides a snapshot of Immunovant's recent corporate activities and disclosures, which can be crucial for investors to understand the company's ongoing compliance and operational status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting on standard corporate events and disclosures, not indicating any immediate material adverse changes.
Key Players & Entities
- Immunovant, Inc. (company) — Registrant
- March 19, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 320 West 37th Street (address) — Principal executive offices
- New York, NY 10018 (address) — Principal executive offices
- 917-580-3099 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Immunovant, Inc.?
This 8-K filing serves to report on various events including Regulation FD disclosures, other events, and financial statements and exhibits as of March 19, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on March 19, 2025.
In which state is Immunovant, Inc. incorporated?
Immunovant, Inc. is incorporated in Delaware.
What is the business address of Immunovant, Inc.?
The business address of Immunovant, Inc. is 320 West 37th Street, New York, NY 10018.
What is the telephone number listed for Immunovant, Inc.?
The telephone number listed for Immunovant, Inc. is (917) 580-3099.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding Immunovant, Inc. (IMVT).